In the article on targeting LPAAT-β in gynecologic cancer in the October 15, 2005 issue of Cancer Research (1), it should be noted that Dr. Gregory M. Springett's research was performed at the Memorial Sloan-Kettering Cancer Center, Developmental Chemotherapy Laboratory, Department of Medicine; he is currently at the H. Lee Moffitt Cancer Center, Drug Discovery Program and Department of Interdisciplinary Oncology. Also, the following should have appeared in the Acknowledgment: We thank the Memorial Sloan-Kettering Cancer Center Molecular Cytology Core for assistance with the confocal microscopy studies, Cyrus Hedvat for constructing the tissue microarrays, Mario Leitao for assistance in obtaining clinical follow-up information, and Jeni Moses for assistance in compound screening.
- Views Icon Views
- Share Icon Share
- Search Site
Article Versions Icon
- Version of Record December 15 2005
Targeting LPAAT-β in Gynecologic Cancer. Cancer Res 15 December 2005; 65 (24): 11785. https://doi.org/10.1158/0008-5472.CAN-65-24-COR1
Download citation file: